
|Articles|July 24, 2016
Specialty Drug Spending Trends Highlight AJPB Week in Review
Author(s)Davy James, Managing Editor
Top articles of the week from The American Journal of Pharmacy Benefits.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADA 2026: Factors Associated With GLP-1 RA Nonresponse in T2D—and What Pharmacists Should Screen For
2
ADA 2026: Earlier GLP-1 and SGLT-2 Use Recommended From Diabetes Diagnosis, Expert Says
3
ADA 2026: Survodutide Cuts Visceral Fat and Normalizes Liver Fat in MASLD. Here's What the Data Mean for Metabolic Risk
4
The Hidden Reimbursement Crisis in Medicare’s Drug Price Negotiation Program
5





































































































































